FRANKLIN WIRELESS CORP. (FKWL) Spending and interest coverage
- R&D / revenue · 12 months: Value 11.13%; Formula and calculation Research and development expense / revenue. Period ending 2026-03-31..
- Stock-based compensation / revenue · 12 months: Value 0.51%; Formula and calculation Share-based compensation / revenue. Period ending 2026-03-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-03-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 11.13% | Research and development expense / revenue. Period ending 2026-03-31. $3.90M ÷ $35.05M × 100 ≈ 11.13% |
| Stock-based compensation / revenue · 12 months | 0.51% | Share-based compensation / revenue. Period ending 2026-03-31. $180.01K ÷ $35.05M × 100 ≈ 0.51% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 3.90M USD | Research and Development Expense |
| Revenue | 35.05M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 180.01K USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -2.19M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $3.90M | $35.05M | $180.01K | $-2.19M | (m) | 11.13% | 0.51% | (m) | (m) |
| 2025-12-31 | $3.88M | $39.61M | $180.01K | $-2.65M | (m) | 9.79% | 0.45% | (m) | (m) |
| 2025-09-30 | $4.03M | $45.51M | $263.21K | $-1.90M | (m) | 8.85% | 0.58% | (m) | (m) |
| 2025-06-30 | $4.10M | $46.09M | $350.59K | $-2.86M | (m) | 8.90% | 0.76% | (m) | (m) |
| 2025-03-31 | $3.62M | $45.28M | $256.83K | $-3.79M | (m) | 8.00% | 0.57% | (m) | (m) |
| 2024-12-31 | $3.64M | $43.44M | $326.91K | $-3.38M | (m) | 8.38% | 0.75% | (m) | (m) |
| 2024-09-30 | $3.56M | $34.46M | $330.90K | $-5.73M | (m) | 10.34% | 0.96% | (m) | (m) |
| 2024-06-30 | $3.41M | $30.80M | $295.10K | $-5.94M | (m) | 11.06% | 0.96% | (m) | (m) |
| 2024-03-31 | $3.45M | $41.68M | $382.81K | $-3.59M | (m) | 8.28% | 0.92% | (m) | (m) |
| 2023-12-31 | $3.69M | $47.36M | $489.13K | $-2.51M | (m) | 7.80% | 1.03% | (m) | (m) |
| 2023-09-30 | $3.82M | $47.50M | $581.71K | $-2.32M | (m) | 8.03% | 1.22% | (m) | (m) |
| 2023-06-30 | $3.92M | $45.95M | $710.87K | $-2.35M | (m) | 8.53% | 1.55% | (m) | (m) |
| 2023-03-31 | $4.10M | $41.09M | $709.15K | $-2.97M | (m) | 9.98% | 1.73% | (m) | (m) |
| 2022-12-31 | $4.10M | $35.92M | $713.90K | $-3.58M | (m) | 11.41% | 1.99% | (m) | (m) |
| 2022-09-30 | $4.23M | $28.76M | $632.05K | $-3.98M | (m) | 14.71% | 2.20% | (m) | (m) |
| 2022-06-30 | $4.28M | $24.00M | $545.84K | $-4.97M | (m) | 17.84% | 2.27% | (m) | (m) |
| 2022-03-31 | $4.42M | $22.82M | $472.25K | $-4.77M | (m) | 19.36% | 2.07% | (m) | (m) |
| 2021-12-31 | $4.57M | $60.46M | $388.99K | $1.54M | (m) | 7.55% | 0.64% | (m) | (m) |
| 2021-09-30 | $4.61M | $124.89M | $389.31K | $12.04M | (m) | 3.69% | 0.31% | (m) | (m) |
| 2021-06-30 | $4.57M | $184.12M | $380.76K | $22.82M | (m) | 2.48% | 0.21% | (m) | (m) |
| 2021-03-31 | $4.32M | $210.54M | (m) | $27.93M | (m) | 2.05% | (m) | (m) | (m) |
| 2020-12-31 | $3.96M | $181.76M | (m) | $23.91M | (m) | 2.18% | (m) | (m) | (m) |
| 2020-09-30 | $3.83M | $128.77M | (m) | $15.97M | (m) | 2.97% | (m) | (m) | (m) |
| 2020-06-30 | $3.75M | $75.07M | (m) | $7.08M | (m) | 4.99% | (m) | (m) | (m) |
| 2020-03-31 | $3.52M | $42.67M | (m) | $1.17M | (m) | 8.26% | (m) | (m) | (m) |
| 2019-12-31 | $3.40M | $36.09M | (m) | $-434.76K | (m) | 9.43% | (m) | (m) | (m) |
| 2019-09-30 | $3.09M | $32.01M | (m) | $-1.94M | (m) | 9.67% | (m) | (m) | (m) |
| 2019-06-30 | $2.96M | $36.47M | (m) | $-2.11M | (m) | 8.10% | (m) | (m) | (m) |
| 2019-03-31 | $2.92M | $38.98M | (m) | $-2.12M | (m) | 7.48% | (m) | (m) | (m) |
| 2018-12-31 | $2.95M | $36.58M | (m) | $-2.15M | (m) | 8.06% | (m) | (m) | (m) |
| 2018-09-30 | $3.18M | $35.75M | (m) | $-1.96M | (m) | 8.90% | (m) | (m) | (m) |
| 2018-06-30 | $3.37M | $30.07M | $0.00 | $-2.69M | (m) | 11.22% | 0.00% | (m) | (m) |
| 2018-03-31 | $3.50M | (m) | $0.00 | $-1.60M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $3.64M | (m) | $0.00 | $-1.26M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $3.59M | (m) | $-12.50K | $-116.23K | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $3.45M | (m) | $-25.00K | $874.38K | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $3.37M | (m) | $-37.50K | $1.38M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $3.17M | (m) | $-50.00K | $1.92M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $3.07M | (m) | $-50.00K | $2.40M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $2.99M | (m) | $-50.00K | $2.12M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $2.89M | (m) | $-29.74K | $1.49M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $2.92M | (m) | $-7.47K | $1.06M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $2.86M | (m) | $-33.62K | $464.55K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $2.92M | (m) | $60.48K | $511.66K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $2.94M | (m) | $25.50K | $77.97K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $2.92M | (m) | $81.00K | $-707.45K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $2.88M | (m) | $184.92K | $-1.18M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $2.78M | (m) | $168.58K | $-2.91M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $2.70M | (m) | $261.06K | $-2.22M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $2.62M | (m) | $266.10K | $-1.71M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $2.74M | (m) | $276.10K | $-3.03M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $2.77M | (m) | $286.10K | $-168.84K | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $2.09M | (m) | $278.28K | $527.00K | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $1.96M | (m) | $273.52K | $-320.95K | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $1.57M | (m) | $258.24K | $-62.02K | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $1.36M | (m) | $224.53K | $-2.26M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $2.45M | (m) | $800.76K | $5.65M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| CLEARONE INC (CLRO) | United States | $0.009B | |
| DNA X, Inc. (SONM) | United States | $0.006B | -0.90 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |